206 research outputs found
Desempenho de suínos alimentados com diferentes concentrados vitamínico-minerálicos.
bitstream/item/59173/1/CUsersPiazzonDocuments43.pd
Teste de concentrados vitamínicos-minerálicos para suínos.
bitstream/item/59154/1/CUsersPiazzonDocuments58.pd
Desempenho de suínos alimentados com diferentes concentrados protéicos.
bitstream/item/59336/1/CUsersPiazzonDocuments19.pd
Desempenho de suinos submetidos a dietas com diferentes nucleos de minerais e vitaminas.
bitstream/item/58900/1/CUsersPiazzonDocuments132.pd
Avaliacao biologica de concentrados comerciais para suinos em crescimento e terminacao.
bitstream/item/121850/1/CNPSA-COM.-TEC.-108-86.pd
Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
Background Despite strong recommendations for colorectal cancer (CRC)
screening, participation rates are low. Understanding factors that affect
screening choices is essential to developing future screening strategies.
Therefore, this study assessed patient willingness to use non-invasive stool
or blood based screening tests after refusing colonoscopy. Methods
Participants were recruited during regular consultations. Demographic, health,
psychological and socioeconomic factors were recorded. All subjects were
advised to undergo screening by colonoscopy. Subjects who refused colonoscopy
were offered a choice of non-invasive tests. Subjects who selected stool
testing received a collection kit and instructions; subjects who selected
plasma testing had a blood draw during the office visit. Stool samples were
tested with the Hb/Hp Complex Elisa test, and blood samples were tested with
the Epi proColon® 2.0 test. Patients who were positive for either were advised
to have a diagnostic colonoscopy. Results 63 of 172 subjects were compliant to
screening colonoscopy (37%). 106 of the 109 subjects who refused colonoscopy
accepted an alternative non-invasive method (97%). 90 selected the Septin9
blood test (83%), 16 selected a stool test (15%) and 3 refused any test (3%).
Reasons for blood test preference included convenience of an office draw,
overall convenience and less time consuming procedure. Conclusions 97% of
subjects refusing colonoscopy accepted a non-invasive screening test of which
83% chose the Septin9 blood test. The observation that participation can be
increased by offering non-invasive tests, and that a blood test is the
preferred option should be validated in a prospective trial in the screening
setting
FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas
Colorectal carcinoma cells have recently been shown to express Fas ligand (FasL). This ligand could allow the tumour cells to evade activated tumour-infiltrating lymphocytes (TILs) by inducing their apoptosis and would thus promote tumour survival and possibly metastasis formation. To test this hypothesis in vivo we analysed the expression of FasL mRNA and protein in paired tissue samples of normal colonic mucosa (N), primary colorectal carcinomas (T) and their metastases (M) from a total of 21 patients by four different methods. Additionally, the presence and activation status of infiltrating lymphocytes, which might contribute to the total amount of FasL in the tissue, was determined by semiquantitative reverse transcription–polymerase chain reaction (RT–PCR) in the same samples. The frequency of FasL detection was 30–40% in T and was 60–100% in M, depending on the sensitivity of the method. Simultaneously, the amount of CD25 mRNA, used as a measure of the number of activated TILs, was in 90% of patients lower in M than in T. The increased frequency of FasL detection in liver metastases was therefore not due to the presence of activated TILs. We conclude that metastasizing subpopulations of colorectal tumour cells express FasL more frequently than the primary carcinomas and may be able to eliminate activated TILs in vivo via Fas/FasL-induced apoptosis or other hitherto unknown mechanisms. © 1999 Cancer Research Campaig
Fractionated γ-irradiation renders tumour cells more responsive to apoptotic signals through CD95
Superantigen reactive Vβ6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cells
The endogenous viral superantigen 7 in DBA/2 mice serves as a target antigen on syngeneic ESb-MP lymphoma cells for allogeneic graft-vs-leukaemia reactive cells. Allogeneic viral superantigen 7 reactive Vβ6+ T cells are able to transfer graft-vs-leukaemia reactivity and to kill specifically viral superantigen 7+ ESb-MP tumour cells in vitro. Here we elucidate the mechanism of this superantigen specific cell lysis. Already 10 min after co-incubation with in vitro stimulated Vβ6+ T cells, viral superantigen 7+ ESb-MP tumour cells show an apoptotic phenotype (Annexin V-positivity, DNA-fragmentation). This extremely rapid type of cell death is not mediated by the death inducing ligands CD95L, TRAIL and TNF but by perforin and granzyme B. Surprisingly, neither mitochondria nor any of the known caspases appear to be involved in this type of tumour cell killing. In contrast, nitric oxide, released by activated macrophages and endothelial cells, induces in the same tumour cells another type of apoptosis which is much slower and involves mitochondria and caspase activation. A synergistic effect between the two different effector mechanisms of superantigen reactive donor cytotoxic T lymphocytes and nitric oxide releasing host macrophages and endothelial cells might explain the effective immune rejection of even advanced metastasised cancer in this graft-vs-leukaemia animal model
Program design features that can improve participation in health education interventions
<p>Abstract</p> <p>Background</p> <p>Although there have been reported benefits of health education interventions across various health issues, the key to program effectiveness is participation and retention. Unfortunately, not everyone is willing to participate in health interventions upon invitation. In fact, health education interventions are vulnerable to low participation rates. The objective of this study was to identify design features that may increase participation in health education interventions and evaluation surveys, and to maximize recruitment and retention efforts in a general ambulatory population.</p> <p>Methods</p> <p>A cross-sectional questionnaire was administered to 175 individuals in waiting rooms of two hospitals diagnostic centres in Toronto, Canada. Subjects were asked about their willingness to participate, in principle, and the extent of their participation (frequency and duration) in health education interventions under various settings and in intervention evaluation surveys using various survey methods.</p> <p>Results</p> <p>The majority of respondents preferred to participate in one 30–60 minutes education intervention session a year, in hospital either with a group or one-on-one with an educator. Also, the majority of respondents preferred to spend 20–30 minutes each time, completing one to two evaluation surveys per year in hospital or by mail.</p> <p>Conclusion</p> <p>When designing interventions and their evaluation surveys, it is important to consider the preferences for setting, length of participation and survey method of your target population, in order to maximize recruitment and retention efforts. Study respondents preferred short and convenient health education interventions and surveys. Therefore, brevity, convenience and choice appear to be important when designing education interventions and evaluation surveys from the perspective of our target population.</p
- …